Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Hereditary Angioedema Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hereditary Angioedema Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hereditary Angioedema Treatment Overall Market Size
2.1 Global Hereditary Angioedema Treatment Market Size: 2022 VS 2029
2.2 Global Hereditary Angioedema Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hereditary Angioedema Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Hereditary Angioedema Treatment Players in Global Market
3.2 Top Global Hereditary Angioedema Treatment Companies Ranked by Revenue
3.3 Global Hereditary Angioedema Treatment Revenue by Companies
3.4 Global Hereditary Angioedema Treatment Sales by Companies
3.5 Global Hereditary Angioedema Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hereditary Angioedema Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hereditary Angioedema Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hereditary Angioedema Treatment Players in Global Market
3.8.1 List of Global Tier 1 Hereditary Angioedema Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Hereditary Angioedema Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hereditary Angioedema Treatment Market Size Markets, 2022 & 2029
4.1.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
4.1.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
4.1.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
4.1.5 Others (Conventional Drugs, Pipeline Drugs)
4.2 By Type - Global Hereditary Angioedema Treatment Revenue & Forecasts
4.2.1 By Type - Global Hereditary Angioedema Treatment Revenue, 2018-2023
4.2.2 By Type - Global Hereditary Angioedema Treatment Revenue, 2024-2029
4.2.3 By Type - Global Hereditary Angioedema Treatment Revenue Market Share, 2018-2029
4.3 By Type - Global Hereditary Angioedema Treatment Sales & Forecasts
4.3.1 By Type - Global Hereditary Angioedema Treatment Sales, 2018-2023
4.3.2 By Type - Global Hereditary Angioedema Treatment Sales, 2024-2029
4.3.3 By Type - Global Hereditary Angioedema Treatment Sales Market Share, 2018-2029
4.4 By Type - Global Hereditary Angioedema Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hereditary Angioedema Treatment Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Others (online pharmacies, mail pharmacies)
5.2 By Application - Global Hereditary Angioedema Treatment Revenue & Forecasts
5.2.1 By Application - Global Hereditary Angioedema Treatment Revenue, 2018-2023
5.2.2 By Application - Global Hereditary Angioedema Treatment Revenue, 2024-2029
5.2.3 By Application - Global Hereditary Angioedema Treatment Revenue Market Share, 2018-2029
5.3 By Application - Global Hereditary Angioedema Treatment Sales & Forecasts
5.3.1 By Application - Global Hereditary Angioedema Treatment Sales, 2018-2023
5.3.2 By Application - Global Hereditary Angioedema Treatment Sales, 2024-2029
5.3.3 By Application - Global Hereditary Angioedema Treatment Sales Market Share, 2018-2029
5.4 By Application - Global Hereditary Angioedema Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Hereditary Angioedema Treatment Market Size, 2022 & 2029
6.2 By Region - Global Hereditary Angioedema Treatment Revenue & Forecasts
6.2.1 By Region - Global Hereditary Angioedema Treatment Revenue, 2018-2023
6.2.2 By Region - Global Hereditary Angioedema Treatment Revenue, 2024-2029
6.2.3 By Region - Global Hereditary Angioedema Treatment Revenue Market Share, 2018-2029
6.3 By Region - Global Hereditary Angioedema Treatment Sales & Forecasts
6.3.1 By Region - Global Hereditary Angioedema Treatment Sales, 2018-2023
6.3.2 By Region - Global Hereditary Angioedema Treatment Sales, 2024-2029
6.3.3 By Region - Global Hereditary Angioedema Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Hereditary Angioedema Treatment Revenue, 2018-2029
6.4.2 By Country - North America Hereditary Angioedema Treatment Sales, 2018-2029
6.4.3 US Hereditary Angioedema Treatment Market Size, 2018-2029
6.4.4 Canada Hereditary Angioedema Treatment Market Size, 2018-2029
6.4.5 Mexico Hereditary Angioedema Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Hereditary Angioedema Treatment Revenue, 2018-2029
6.5.2 By Country - Europe Hereditary Angioedema Treatment Sales, 2018-2029
6.5.3 Germany Hereditary Angioedema Treatment Market Size, 2018-2029
6.5.4 France Hereditary Angioedema Treatment Market Size, 2018-2029
6.5.5 U.K. Hereditary Angioedema Treatment Market Size, 2018-2029
6.5.6 Italy Hereditary Angioedema Treatment Market Size, 2018-2029
6.5.7 Russia Hereditary Angioedema Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Hereditary Angioedema Treatment Market Size, 2018-2029
6.5.9 Benelux Hereditary Angioedema Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Hereditary Angioedema Treatment Revenue, 2018-2029
6.6.2 By Region - Asia Hereditary Angioedema Treatment Sales, 2018-2029
6.6.3 China Hereditary Angioedema Treatment Market Size, 2018-2029
6.6.4 Japan Hereditary Angioedema Treatment Market Size, 2018-2029
6.6.5 South Korea Hereditary Angioedema Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Hereditary Angioedema Treatment Market Size, 2018-2029
6.6.7 India Hereditary Angioedema Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Hereditary Angioedema Treatment Revenue, 2018-2029
6.7.2 By Country - South America Hereditary Angioedema Treatment Sales, 2018-2029
6.7.3 Brazil Hereditary Angioedema Treatment Market Size, 2018-2029
6.7.4 Argentina Hereditary Angioedema Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hereditary Angioedema Treatment Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Hereditary Angioedema Treatment Sales, 2018-2029
6.8.3 Turkey Hereditary Angioedema Treatment Market Size, 2018-2029
6.8.4 Israel Hereditary Angioedema Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Hereditary Angioedema Treatment Market Size, 2018-2029
6.8.6 UAE Hereditary Angioedema Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CSL
7.1.1 CSL Company Summary
7.1.2 CSL Business Overview
7.1.3 CSL Hereditary Angioedema Treatment Major Product Offerings
7.1.4 CSL Hereditary Angioedema Treatment Sales and Revenue in Global (2018-2023)
7.1.5 CSL Key News & Latest Developments
7.2 Pharming Group
7.2.1 Pharming Group Company Summary
7.2.2 Pharming Group Business Overview
7.2.3 Pharming Group Hereditary Angioedema Treatment Major Product Offerings
7.2.4 Pharming Group Hereditary Angioedema Treatment Sales and Revenue in Global (2018-2023)
7.2.5 Pharming Group Key News & Latest Developments
7.3 Shire plc (Takeda Pharmaceutical Company Limited)
7.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Company Summary
7.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
7.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Major Product Offerings
7.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales and Revenue in Global (2018-2023)
7.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Key News & Latest Developments
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Company Summary
7.4.2 Ionis Pharmaceuticals Business Overview
7.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Major Product Offerings
7.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Ionis Pharmaceuticals Key News & Latest Developments
7.5 Attune Pharmaceuticals
7.5.1 Attune Pharmaceuticals Company Summary
7.5.2 Attune Pharmaceuticals Business Overview
7.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Major Product Offerings
7.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales and Revenue in Global (2018-2023)
7.5.5 Attune Pharmaceuticals Key News & Latest Developments
7.6 BioCryst Pharmaceuticals
7.6.1 BioCryst Pharmaceuticals Company Summary
7.6.2 BioCryst Pharmaceuticals Business Overview
7.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Major Product Offerings
7.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales and Revenue in Global (2018-2023)
7.6.5 BioCryst Pharmaceuticals Key News & Latest Developments
7.7 KalVista Pharmaceuticals
7.7.1 KalVista Pharmaceuticals Company Summary
7.7.2 KalVista Pharmaceuticals Business Overview
7.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Major Product Offerings
7.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales and Revenue in Global (2018-2023)
7.7.5 KalVista Pharmaceuticals Key News & Latest Developments
8 Global Hereditary Angioedema Treatment Production Capacity, Analysis
8.1 Global Hereditary Angioedema Treatment Production Capacity, 2018-2029
8.2 Hereditary Angioedema Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Hereditary Angioedema Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hereditary Angioedema Treatment Supply Chain Analysis
10.1 Hereditary Angioedema Treatment Industry Value Chain
10.2 Hereditary Angioedema Treatment Upstream Market
10.3 Hereditary Angioedema Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hereditary Angioedema Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer